Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Effect of vırtual realıty on paın and Sleep qualıty ın Women

3 juni 2026 bijgewerkt door: Remzi KARASUNGUR, Hasan Kalyoncu University

The Effect of vıdeo Watched wıth musıc Through vırtual realıty Glasses and musıc lıstenıng Alone on paın and Sleep qualıty ın Women wıth Dysmenorrhea

The aim of this study is to determine whether a video viewed through virtual reality goggles accompanied by music has an effect on pain and sleep quality in women with dysmenorrhea. The main questions it seeks to answer are as follows:

  • Does watching a video through virtual reality goggles accompanied by music reduce pain in women with dysmenorrhea?
  • Does watching a video through virtual reality goggles accompanied by music improve sleep quality in women with dysmenorrhea? The study will compare a group that uses music from the virtual reality video with another group to determine whether the virtual reality application has an effect on pain and sleep quality.

Participants will do the following:

For 3 days, use the virtual reality or music application every evening before going to bed after completing the VAS. The next day, after waking up, complete the VAS and the sleep quality scale and record the results.

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Studietype

Ingrijpend

Inschrijving (Werkelijk)

77

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Baykan
      • Siirt, Baykan, Turkije (Türkiye), 56460
        • Baykan State Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Women who volunteered to participate in the study,
  • Who are at least literate,
  • Aged 15-49 and not yet in menopause,
  • Who are not pregnant,
  • Who have been diagnosed with dysmenorrhea by a physician and have a pain intensity of at least 4 on the Visual Analogue Scale

Exclusion Criteria:

  • Women with dysmenorrhea pain intensity below 4 on the Visual Analog Scale,
  • Women with vision or hearing impairments,
  • Women who are unwilling to participate in the study,
  • Women using analgesic medications for menstrual pain,
  • Pregnant women

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Verviervoudigen

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: experiment
Group shown a video using a virtual reality headset: For this experiment, a video featuring nature scenes and waterfalls was downloaded to a phone, loaded into a virtual reality headset, and provided to the participant ready for use.

Group shown a video using a virtual reality headset: A video containing images of nature and waterfalls is downloaded to a phone and provided to the participant ready to use inside a virtual reality headset; the procedure is carried out as described below.

For three consecutive days, each day:

  • After menstruation begins, apply the VAS pain scale before going to bed in the evening
  • In the evening, in a dark and quiet environment, watch the 30-minute virtual reality video as instructed by the researcher until falling asleep
  • The following morning, apply the VAS pain scale and RCUÖ and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Andere namen:
  • Virtuele realiteit
Placebo-vergelijker: control
Unlike the intervention group, the women in the control group were given MP3 players by the researcher, instructed on how to use them, and had the music used in the virtual reality video loaded onto the devices for them to listen to.

Unlike the intervention group, the women in the control group were given an MP3 player by the researcher, instructed on how to use it, and had the music used in the virtual reality video loaded onto it for them to listen to.

For three consecutive days, each day:

  • Apply the VAS pain scale in the evening before going to bed after menstruation has occurred
  • Listen to the 30-minute music in a dark and quiet environment in the evening, as instructed by the researcher
  • Apply the VAS pain scale and RCUÖ the following morning and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Andere namen:
  • muziek

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Distribution of women according to the characteristics of their menstrual cycles
Tijdsspanne: 4 weeks
This table includes the latest menstrual pain scale, the occurrence of pain during the menstrual cycle, the type of dysmenorrhea, the timing of dysmenorrhea, information about menstruation, who provided information about menstruation, the use of pain relievers during the menstrual period, non-pharmacological interventions used to alleviate menstrual pain, non-pharmacological interventions used to alleviate menstrual pain, the presence of dysmenorrhea in the family, and gynecological diagnosis data. Patients with a pain scale (VAS) score of 4 or higher were evaluated, and the analysis proceeded to secondary outcomes.
4 weeks

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Comparison of Participants' Sociodemographic Characteristics by Group
Tijdsspanne: 2 weeks
This table presents sociodemographic data such as women's marital status, age, and chronic conditions.
2 weeks
A Comparison of Certain Characteristics of Participants' Menstrual Cycles Across Groups
Tijdsspanne: 4 weeks
This table presents data such as the age at first menstruation, menstrual cycle length, and duration of menstrual bleeding
4 weeks
Comparison of Dysmenorrhea Characteristics Among Participants by Group
Tijdsspanne: 4 weeks
This table examines data such as the onset of dysmenorrhea, the presence of dysmenorrhea in the family, the family history of dysmenorrhea, the severity of pain during menstruation, and the use of pain relievers during menstruation.
4 weeks
Comparison of Participants' Sleep-Related Characteristics by Group
Tijdsspanne: 4 weeks
This table provides information on a woman's sleep patterns during her menstrual cycle
4 weeks
Comparisons of Participants' Visual Analog Scale (VAS) Scores Between and Within Groups
Tijdsspanne: 6 weeks

A visual analog scale is a pain assessment tool where individuals mark their pain level on a horizontal bar ranging from 0 to 10. The starting point of the scale indicates the absence of pain, while the end point indicates that the pain is unbearable.

This table shows the woman's pain scale assessment.

6 weeks
Comparisons of Participants' Richard Campbell Sleep Scale (RCSQ) Scores Across and Within Groups
Tijdsspanne: 6 weeks
The Richard Campbell Sleep Scale assesses the depth of sleep, the time it takes to fall asleep, the frequency of waking, the duration of wakefulness upon waking, the quality of sleep, and the noise level in the environment. Each item on the scale is scored on a scale of 0 to 100. A score of "0-25" indicates "very poor sleep," while a score of "76-100" indicates "very good sleep." When calculating the total scale score, the scores from the 5 items are added together; the noise level in the environment is not included in the total score calculation.
6 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie directeur: Remzi KARASUNGUR, not affiliated

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

5 januari 2023

Primaire voltooiing (Werkelijk)

29 maart 2023

Studie voltooiing (Werkelijk)

24 september 2023

Studieregistratiedata

Eerst ingediend

7 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

3 juni 2026

Eerst geplaatst (Werkelijk)

8 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

8 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

3 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Beschrijving IPD-plan

When our study is published as an article, the data on the individuals will be presented to researchers in tabular

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren